Primary fallopian tube carcinoma

A retrospective clinicopathologic study

P. Singhal, K. Odunsi, Kerry J Rodabaugh, D. Driscoll, S. Lele

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Introduction: Primary fallopian tube carcinoma is a rare tumor. The aim of this study was to evaluate clinical characteristics and management of fallopian tube malignancies at a large tertiary care cancer institute. Methods: A retrospective review of the Tumor Registry was conducted to identify all primary fallopian tube carcinomas between 1980 and 2001. Medical charts were retrospectively reviewed. Primary endpoints were overall survival and disease recurrence. Results: Thirty-five patients had histology consistent with fallopian tube carcinoma. The median age at diagnosis was 56 years. The most common signs or symptoms were abnormal vaginal bleeding (29%) and abdominal/pelvic mass (26%). The most common histology was adenocarcinoma in 16 (46%) patients. Five patients (14%) were Stage I, seven patients (20%) Stage II, 17 patients (49%) Stage III and six patients (17%) Stage IV. Thirty-two (91%) patients received adjuvant chemotherapy and 77% received platinum-based chemotherapy. Twenty-seven (77%) patients underwent second-look surgery, of which 17 patients (63%) were positive for disease. The 5-year survival rate was 64% for Stage I, 42% for Stage II, 32% for Stage III, and 17% for Stage IV. Conclusions: Fallopian tube malignancies are rare and carry a poor prognosis. More extensive research needs to be performed to have definitive etiologic, diagnostic and treatment guidelines.

Original languageEnglish (US)
Pages (from-to)16-18
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Volume27
Issue number1
StatePublished - Mar 23 2006

Fingerprint

Fallopian Tubes
Retrospective Studies
Carcinoma
Neoplasms
Histology
Second-Look Surgery
Uterine Hemorrhage
Tertiary Healthcare
Adjuvant Chemotherapy
Platinum
Signs and Symptoms
Registries
Adenocarcinoma
Survival Rate
Guidelines
Recurrence
Drug Therapy
Survival

Keywords

  • Chemotherapy
  • Fallopian tube cancer
  • Second-look surgery

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Primary fallopian tube carcinoma : A retrospective clinicopathologic study. / Singhal, P.; Odunsi, K.; Rodabaugh, Kerry J; Driscoll, D.; Lele, S.

In: European Journal of Gynaecological Oncology, Vol. 27, No. 1, 23.03.2006, p. 16-18.

Research output: Contribution to journalReview article

Singhal, P. ; Odunsi, K. ; Rodabaugh, Kerry J ; Driscoll, D. ; Lele, S. / Primary fallopian tube carcinoma : A retrospective clinicopathologic study. In: European Journal of Gynaecological Oncology. 2006 ; Vol. 27, No. 1. pp. 16-18.
@article{55135014795d4f38bb428c3150ee5c14,
title = "Primary fallopian tube carcinoma: A retrospective clinicopathologic study",
abstract = "Introduction: Primary fallopian tube carcinoma is a rare tumor. The aim of this study was to evaluate clinical characteristics and management of fallopian tube malignancies at a large tertiary care cancer institute. Methods: A retrospective review of the Tumor Registry was conducted to identify all primary fallopian tube carcinomas between 1980 and 2001. Medical charts were retrospectively reviewed. Primary endpoints were overall survival and disease recurrence. Results: Thirty-five patients had histology consistent with fallopian tube carcinoma. The median age at diagnosis was 56 years. The most common signs or symptoms were abnormal vaginal bleeding (29{\%}) and abdominal/pelvic mass (26{\%}). The most common histology was adenocarcinoma in 16 (46{\%}) patients. Five patients (14{\%}) were Stage I, seven patients (20{\%}) Stage II, 17 patients (49{\%}) Stage III and six patients (17{\%}) Stage IV. Thirty-two (91{\%}) patients received adjuvant chemotherapy and 77{\%} received platinum-based chemotherapy. Twenty-seven (77{\%}) patients underwent second-look surgery, of which 17 patients (63{\%}) were positive for disease. The 5-year survival rate was 64{\%} for Stage I, 42{\%} for Stage II, 32{\%} for Stage III, and 17{\%} for Stage IV. Conclusions: Fallopian tube malignancies are rare and carry a poor prognosis. More extensive research needs to be performed to have definitive etiologic, diagnostic and treatment guidelines.",
keywords = "Chemotherapy, Fallopian tube cancer, Second-look surgery",
author = "P. Singhal and K. Odunsi and Rodabaugh, {Kerry J} and D. Driscoll and S. Lele",
year = "2006",
month = "3",
day = "23",
language = "English (US)",
volume = "27",
pages = "16--18",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "1",

}

TY - JOUR

T1 - Primary fallopian tube carcinoma

T2 - A retrospective clinicopathologic study

AU - Singhal, P.

AU - Odunsi, K.

AU - Rodabaugh, Kerry J

AU - Driscoll, D.

AU - Lele, S.

PY - 2006/3/23

Y1 - 2006/3/23

N2 - Introduction: Primary fallopian tube carcinoma is a rare tumor. The aim of this study was to evaluate clinical characteristics and management of fallopian tube malignancies at a large tertiary care cancer institute. Methods: A retrospective review of the Tumor Registry was conducted to identify all primary fallopian tube carcinomas between 1980 and 2001. Medical charts were retrospectively reviewed. Primary endpoints were overall survival and disease recurrence. Results: Thirty-five patients had histology consistent with fallopian tube carcinoma. The median age at diagnosis was 56 years. The most common signs or symptoms were abnormal vaginal bleeding (29%) and abdominal/pelvic mass (26%). The most common histology was adenocarcinoma in 16 (46%) patients. Five patients (14%) were Stage I, seven patients (20%) Stage II, 17 patients (49%) Stage III and six patients (17%) Stage IV. Thirty-two (91%) patients received adjuvant chemotherapy and 77% received platinum-based chemotherapy. Twenty-seven (77%) patients underwent second-look surgery, of which 17 patients (63%) were positive for disease. The 5-year survival rate was 64% for Stage I, 42% for Stage II, 32% for Stage III, and 17% for Stage IV. Conclusions: Fallopian tube malignancies are rare and carry a poor prognosis. More extensive research needs to be performed to have definitive etiologic, diagnostic and treatment guidelines.

AB - Introduction: Primary fallopian tube carcinoma is a rare tumor. The aim of this study was to evaluate clinical characteristics and management of fallopian tube malignancies at a large tertiary care cancer institute. Methods: A retrospective review of the Tumor Registry was conducted to identify all primary fallopian tube carcinomas between 1980 and 2001. Medical charts were retrospectively reviewed. Primary endpoints were overall survival and disease recurrence. Results: Thirty-five patients had histology consistent with fallopian tube carcinoma. The median age at diagnosis was 56 years. The most common signs or symptoms were abnormal vaginal bleeding (29%) and abdominal/pelvic mass (26%). The most common histology was adenocarcinoma in 16 (46%) patients. Five patients (14%) were Stage I, seven patients (20%) Stage II, 17 patients (49%) Stage III and six patients (17%) Stage IV. Thirty-two (91%) patients received adjuvant chemotherapy and 77% received platinum-based chemotherapy. Twenty-seven (77%) patients underwent second-look surgery, of which 17 patients (63%) were positive for disease. The 5-year survival rate was 64% for Stage I, 42% for Stage II, 32% for Stage III, and 17% for Stage IV. Conclusions: Fallopian tube malignancies are rare and carry a poor prognosis. More extensive research needs to be performed to have definitive etiologic, diagnostic and treatment guidelines.

KW - Chemotherapy

KW - Fallopian tube cancer

KW - Second-look surgery

UR - http://www.scopus.com/inward/record.url?scp=33644946958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644946958&partnerID=8YFLogxK

M3 - Review article

VL - 27

SP - 16

EP - 18

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 1

ER -